Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma.
Cheng Y, Hou K, Wang Y, Chen Y, Zheng X, Qi J, Yang B, Tang S, Han X, Shi D, Wang X, Liu Y, Hu X, Che X.
Cheng Y, et al. Among authors: hou k.
Front Oncol. 2021 Jun 24;11:665276. doi: 10.3389/fonc.2021.665276. eCollection 2021.
Front Oncol. 2021.
PMID: 34249701
Free PMC article.